טוען...
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
BACKGROUND: The relative risk (RR) of infection for patients treated with immune checkpoint inhibitors (ICIs) is unknown. OBJECTIVES: This study evaluated the risk of infection for patients with solid tumors undergoing ICI therapy based on a systematic review and meta-analysis. PATIENTS AND METHODS:...
שמור ב:
| הוצא לאור ב: | Target Oncol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8256230/ https://ncbi.nlm.nih.gov/pubmed/34224061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-021-00824-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|